Industry steps up interest in developing world, fueling doubling of R&D pipeline

The Foundation's 10-year analysis on the pharmaceutical industry and global health is covered by Nick Paul Taylor in this piece for FierceBiotech. Nick reports on the findings that the pipeline of drugs and vaccines aimed at diseases prevalent in low- and middle-income countries has more than doubled since 2014.